They emphasize the benefits of both vaccines still outweigh the risks.January 13, 2023: Prizer's Omicron (bivalent) booster seemed to be associated with a heightened risk of stroke in patient 65 and older for three weeks after getting the shot, according to data from the Vaccine Safety Datalink, a federal safety surveillance system
[ 4 ] However, enthusiasm surrounding DSIP was shaken due to difficulties replicating the original findings
10.1016/j.cell.2017.09.046 309 XiangY.StineZ
In some, it becomes more pronounced because surrounding skin is not as dramatically impacted
However, current evidence predominantly derives from animal models and in vitro systems, underscoring the need for large-scale, multicenter clinical trials in high-altitude populations to validate drug-microbiome interactions
This guide cuts through the marketing